Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb;65(2):261-4.
doi: 10.1136/ard.2005.037523.

Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes

G Tardif  1 , J-P Pelletier, D Hum, C Boileau, N Duval, J Martel-Pelletier
Affiliations

Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes

G Tardif et al. Ann Rheum Dis. 2006 Feb.

Abstract

Objective: To investigate the distribution of the bone morphogenic protein (BMP) antagonist chordin in normal and osteoarthritic cartilage and synovial membranes, and its regulation in chondrocytes and synovial fibroblasts by inflammatory and growth factors.

Methods: Localisation of chordin in tissues was undertaken by immunohistochemistry and gene regulation was determined by real time polymerase chain reaction.

Results: In normal cartilage, chordin was found at low levels (mean (SD), 7.6 (1.3)%), mainly in the very superficial layers. In osteoarthritis, chordin was also found in the superficial layers (8.9 (1.1)%), though at a significantly higher level (24.7 (1.5)%) in the last two thirds of the cartilage. In contrast to normal cells, chordin mRNA and protein levels were significantly downregulated (p<0.01) in osteoarthritic chondrocytes by all the growth factors tested. Interferon gamma stimulated chordin expression in normal but not in osteoarthritic chondrocytes (p<0.0002), while interleukin 1 beta and tumour necrosis factor alpha did not affect the expression level. However, no difference was found in either the distribution or regulation of chordin in normal and osteoarthritic synovial membranes or synovial fibroblasts.

Conclusions: The differential distribution and regulation of chordin in normal and osteoarthritic cartilage and chondrocytes suggests an involvement of this antagonist in the osteoarthritic process.

PubMed Disclaimer

References

    1. Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int 2000572207–2214. - PubMed
    1. Edwards C J, Francis‐West P H. Bone morphogenetic proteins in the development and healing of synovial joints. Semin Arthritis Rheum 20013133–42. - PubMed
    1. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002250231–250. - PubMed
    1. Canalis E, Economides A N, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 200324218–235. - PubMed
    1. Piccolo S, Sasai Y, Lu B, De Robertis E M. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP‐4. Cell 199686589–598. - PMC - PubMed

MeSH terms